CClinicalTrials.gg
Not yet recruitingNCT07539350WECARE 3Updated Sep 23, 2026

WECARE: A Personalized Intervention for High-Demand Dementia Caregivers

An interventional study of WECARE and Equal-attention comparator in Caregiver Burden, sponsored by George Mason University. Not yet recruiting. Open to participants aged 21 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by George Mason University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
21 Years to 100 Years
Sex
All
01

Study summary

The goal of the project is to evaluate Wellness Enhancement for Caregivers (WECARE), a digital behavioral intervention for high-demand dementia caregivers. The behavioral intervention is culturally tailored to the target users and will be delivered via the WECARE mobile app and accompanying website, accessible only to verified enrolled participants. Participants will engage with digital learning materials and supportive resources over the course of the program. The goal is to determine whether this approach improves caregiver well-being and reduces stress related to caregiving.

02

Conditions studied

  • Caregiver Burden

Browse trials for

03

Who can participate

Ages eligible
21 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. currently residing in the United States,
  2. are 21 years of age or older,
  3. own a smartphone or computer, AND
  4. currently care for a family member or loved one who lives of Alzheimer's disease or related dementia and meet one of hte following high-demand criteria:

    1. age 65 or older,
    2. provide 10 or more hours of direct care per week,
    3. work 20 or more hours per week in addition to caregiving,
    4. care for another family member (e.g., a child under 18, another parent, or a spouse); or
    5. experience difficulty covering basic living expenses.

Exclusion criteria

Exclusion Criteria:

  1. evidence or signs of severe cognitive impairment or mental disorders,
  2. the care recipient was receiving hospice care or had a life expectancy of fewer than six months, OR
  3. Unable to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants will first complete a baseline survey online, then access the WECARE program via a project-specific mobile app (WECARE) or its accompanying website and begin receiving the 7-week interactive and personalized program. The program content includes short video clips, pictorial messages, and audio recordings. Each week, the WECARE program is focused on a theme aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Four weeks after the intervention or 11 weeks after the baseline, participants will complete the follow-up survey online. Six months after the baseline, participants will complete the second follow-up survey online. Tweleve months after the baseline, participants will complete the third follow-up survey online.

    Behavioral: WECARE

  • Active comparator
    Control Group

    Participants in this arm will receive equal attention intervention. They will also access the WECARE app and accomanying website to receive the 7-week program featured in general health education. Each week, participants receive health information with a focused theme at the same frequency as the intervention group. Four weeks after the intervention or 11 weeks after the baseline, participants will complete the first follow-up survey online. Six months after the baseline, participants will complete the second follow-up survey online. Tweleve months after the baseline, participants will complete the third follow-up survey online.

    Behavioral: Equal-attention comparator

Interventions

  • BehavioralWECARE

    The 7-week WECARE intervention was designed to improve caregiving skills, alleviate caregiver distress, and enhance the psychosocial well-being of dementia caregivers. The program content includes short video clips, pictorial messages, and audio recordings tailored participants characteristics (e.g., caregiver role, baseline caregiving burden) and personalized to their individual needs based on weekly feedback.

  • BehavioralEqual-attention comparator

    Participants will access the the same WECARE app and accomanying website to receive the 7-week program featured in general health education. Each week, participants receive health information with a focused theme at the same frequency as the intervention group.

05

What researchers measure

Primary outcomes

  1. Efficacy of Behavioral Intervention in Change From Baseline in Depressive Symptoms

    The baseline and follow-up differences in depressive symptoms will be assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item survey instrument designed to measure the frequency and severity of depressive symptoms. The total score is calculated by summing the responses to all 20 items. The total scale ranges from 0 to 60, with higher scores indicating more severe depressive symptoms (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up. adults and dementia caregivers.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

Secondary outcomes

  1. Efficacy of Behavioral Intervention in Change From Baseline in Caregiving Burden

    The baseline and follow-up differences in caregiving burden will be assessed using the 12-item Zarit Burden Interview (ZBI-12). The ZBI-12 is designed to measure the subjective physical, psychological, and social burden experienced by caregivers. Each item is rated on a 5-point scale from "never" (0) to "nearly always" (4), The total score is calculated by summing the responses to all 12 items. The total scale ranges from 0 to 48, with higher scores indicating greater caregiving burden (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

Other outcomes

  1. Efficacy of Behavioral Intervention in Change From Baseline in Life Satisfaction

    The baseline and follow-up differences in life satisfaction will be assessed using the Satisfaction with Life Scale (SWLS). The SWLS is a 5-item survey instrument designed to measure a person's global cognitive judgments of satisfaction with their life. The total score is calculated by summing the responses to all 5 items. The total scale ranges from 0 to 30, with higher scores indicating greater life satisfaction (a better outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

  2. Efficacy of Behavioral Intervention in Change From Baseline in Caregiving Mastery

    The baseline and follow-up differences in caregiving mastery will be assessed using the Caregiving Mastery Scale. This 7-item survey instrument is designed to measure a caregiver's self-perception of their ability to effectively manage caregiving tasks and challenges. The total score is calculated by summing the responses to all 7 items. The total scale ranges from 0 to 28, with higher scores indicating greater caregiving mastery (a better outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

  3. Efficacy of Behavioral Intervention in Change in Care-recipient's Problem Behaviors

    The baseline and follow-up differences in care-recipient problem behaviors will be assessed using the Revised Memory and Problem Behavior Checklist (RMBPC). The RMBPC is a 24-item survey instrument designed to measure observable behavioral problems in care recipients across three subdomains: memory-related issues, depressive behaviors, and disruptive behaviors. The total score is calculated by summing the Yes (1) or No (0) responses to all 24 items. The total scale ranges from 0 to 24, with higher scores indicating a higher frequency of problem behaviors (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

  4. Efficacy of Behavioral Intervention in Change From Baseline in Positive Aspect of Caregiving

    The baseline and follow-up differences in caregivers' positive aspects of caregiving will be measured by Positive Aspects of Caregiving Scale, a 9-item scale 5-point Likert scale from 0 to 4, with total scores ranging from 0 to 36, with higher score indicating more positive perception of caregiving. The baseline and follow-up differences in the scores will be calculated.

    Time frame: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07539350
Lead sponsor
George Mason University
Collaborators
National Institute on Aging (NIA)
Responsible party
Y. Alicia Hong (Professor, George Mason University) — Principal investigator
First posted
Apr 20, 2026
Start date
Nov 2, 2026 (estimated)
Primary completion
Sep 2030 (estimated)
Completion
Oct 2030 (estimated)
Last update
Sep 23, 2026

Study contacts

Kang Shen
Contact
kshen2@gmu.edu
7039931929

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion